Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes

TUESDAY, Oct. 27, 2020 — Testing of Eli Lilly’s antibody drug for hospitalized COVID-19 patients has been halted because the treatment doesn’t help them recover from their infection.
Two weeks ago, enrollment in the study was paused because of a…
Source: Topamax